NORTHERN TRUST CORP - NAVIDEA BIOPHARMACEUTICALS I ownership

NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 28 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of NAVIDEA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q3 2023$3,535
-2.5%
39,4140.0%0.00%
Q2 2023$3,626
-64.6%
39,4140.0%0.00%
Q1 2023$10,248
+23.8%
39,4140.0%0.00%
Q4 2022$8,277
-17.2%
39,4140.0%0.00%
Q3 2022$10,000
-64.3%
39,4140.0%0.00%
Q2 2022$28,000
-9.7%
39,4140.0%0.00%
Q1 2022$31,000
-20.5%
39,4140.0%0.00%
Q4 2021$39,000
-43.5%
39,4140.0%0.00%
Q3 2021$69,000
-4.2%
39,4140.0%0.00%
Q2 2021$72,000
-10.0%
39,4140.0%0.00%
Q1 2021$80,000
-3.6%
39,414
+1.5%
0.00%
Q4 2020$83,000
-14.4%
38,813
+7.8%
0.00%
Q3 2020$97,000
-46.1%
35,991
-21.4%
0.00%
Q2 2020$180,000
+1025.0%
45,794
+108.6%
0.00%
Q1 2020$16,000
-40.7%
21,9510.0%0.00%
Q4 2019$27,000
+237.5%
21,951
+79.4%
0.00%
Q3 2019$8,0000.0%12,2340.0%0.00%
Q2 2019$8,00012,2340.00%
Other shareholders
NAVIDEA BIOPHARMACEUTICALS I shareholders Q4 2022
NameSharesValueWeighting ↓
Allred Capital Management, LLC 466,688$41,8620.02%
Warberg Asset Management LLC 194,997$17,4910.00%
Virtu Financial LLC 333,069$300.00%
UBS Group AG 149,612$13,4660.00%
NewEdge Advisors, LLC 412$360.00%
Parallel Advisors, LLC 350$310.00%
BANK OF AMERICA CORP /DE/ 1,604$1430.00%
WELLS FARGO & COMPANY/MN 5,632$5040.00%
NORTHERN TRUST CORP 39,414$3,5350.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of NAVIDEA BIOPHARMACEUTICALS I shareholders